Market Tracker

09/16 7:10am ET

Salix Pharmaceuticals Ltd (NASDAQ:SLXP)

148.72
Data as of Sep 15
 +5.29 / +3.69%
Today’s Change
65.38
Today|||52-Week Range
162.38
+65.35%
Year-to-Date

Today’s Trading

Previous close143.43
Today’s open143.97
Day’s range-- - --
Volume2,150,484
Average volume (3 months)1,370,903
Market cap$9.1B
Dividend yield--
Data as of 09/15/2014

Growth & Valuation

Earnings growth (last year)+115.84%
Earnings growth (this year)+65.22%
Earnings growth (next 5 years)+18.40%
Revenue growth (last year)+26.98%
P/E ratio177.0
Price/Sales5.95
Price/Book12.18

Competitors

 Today’s
change
Today’s
% change
PCYCPharmacyclics Inc-2.91-2.35%
HSPHospira Inc+0.16+0.30%
MNKMallinckrodt Plc-0.47-0.54%
ENDPEndo International P...+0.15+0.23%
Data as of 09/15/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)$1.58
Annual revenue (last year)$933.8M
Annual profit (last year)$143.0M
Net profit margin15.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Carolyn J. Logan
CFO, Executive VP-Finance &
Administration
Adam C. Derbyshire
Corporate headquarters
Raleigh, North Carolina

Forecasts